Tony Reid
Physician Assistant · Clovis, CANPI 1518004308
Payments from drug & device makers
Across 439 payments — averaging $19.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$731
- Lilly USA, LLC$577
- Amgen$548
- Novo Nordisk$510
- Boehringer Ingelheim$492
- plus $4K from 33 others
What the payments were for
- Food & beverage$8,405100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 99 | $1,694 |
| AstraZeneca | 27 | $731 |
| Lilly USA, LLC | 27 | $577 |
| Amgen | 39 | $548 |
| Novo Nordisk | 20 | $510 |
| Boehringer Ingelheim | 22 | $492 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 39 | $431 |
| Bayer | 17 | $423 |
| GSK | 28 | $353 |
| Otsuka America Pharmaceutical, Inc. | 14 | $317 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $228 |
| Pfizer | 9 | $180 |
| Exact Sciences | 7 | $179 |
| Radius Health, Inc. | 6 | $166 |
| Axsome Therapeutics, Inc. | 5 | $158 |
| Biohaven Pharmaceuticals, Inc. | 8 | $147 |
| Lundbeck LLC | 5 | $135 |
| Boston Scientific | 5 | $131 |
| Idorsia Pharmaceuticals US Inc | 8 | $128 |
| Corium, LLC | 5 | $91 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $86 |
| Eisai Inc. | 4 | $79 |
| Astellas Pharma US Inc | 3 | $71 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $66 |
| Kowa Pharmaceuticals America, Inc. | 3 | $64 |
| Merck | 3 | $62 |
| Amarin Pharma, Inc. | 4 | $61 |
| Abbott | 2 | $50 |
| Ironwood Pharmaceuticals, Inc | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Coloplast | 1 | $26 |
| Agios Pharmaceuticals, Inc. | 1 | $26 |
| Novartis | 1 | $24 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| BD | 1 | $20 |
| Ardelyx, Inc. | 1 | $17 |
| Tolmar, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,405 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $40,909 |
| JardianceEmpagliflozin | 19 | $29,720 |
| OzempicSemaglutide | 14 | $22,654 |
| TrulicityDulaglutide | 13 | $20,722 |
| Celecoxib | 106 | $6,810 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 133 | $3,885 |
| Wixela InhubFluticasone Propion/Salmeterol | 27 | $3,396 |
| Atorvastatin Calcium | 188 | $2,952 |
| Levothyroxine Sodium | 112 | $1,849 |
| Gabapentin | 113 | $1,597 |
| Ventolin HfaAlbuterol Sulfate | 25 | $1,335 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $1,270 |
| Fenofibrate | 20 | $1,165 |
| SynthroidLevothyroxine Sodium | 27 | $1,136 |
| Pioglitazone Hcl | 51 | $1,086 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $353 | $40,90957 claims |
| Boehringer IngelheimJardiance | $492 | $29,72019 claims |
| Novo NordiskOzempic | $510 | $22,65414 claims |
| Lilly USA, LLCTrulicity | $577 | $20,72213 claims |
| AbbVieSynthroid | $1,694 | $1,13627 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Clovis
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Eric CheungLos Angeles$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.